Oral administration of a bacterial immunomodulator enhances the immune response to cholera toxin

By Flo J.   Goldman H.   Roux M.E.   Massouh E.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1167-1173

Elsevier

Access to resources Recommend Favorite

Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid

By Isaka M.   Yasuda Y.   Kozuka S.   Taniguchi T.   Miura Y.   Matano K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 944-948

Elsevier

Access to resources Recommend Favorite

Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion

By Myc A.   Kukowska-Latallo J.F.   Bielinska A.U.   Cao P.   Myc P.P.   Janczak K.   Sturm T.R.   Grabinski M.S.   Landers J.J.   Young K.S.   Chang J.   Hamouda T.   Olszewski M.A.   Baker J.R.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3801-3814

Elsevier

Access to resources Recommend Favorite

Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres

By Tabata Y.   Inoue Y.   Ikada Y.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1677-1685

Elsevier

Access to resources Recommend Favorite

Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice

By Li T.-C.   Takeda N.   Miyamura T.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3476-3484

Elsevier

Access to resources Recommend Favorite